A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-4527|6|1|81-96

ISSN： 2050-4527

Source： Immunity, Inflammation And Disease, Vol.6, Iss.1, 2018-03, pp. : 81-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy of asthma using CpG oligodeoxynucleotides

By Kline Joel

Immunologic Research, Vol. 39, Iss. 1-3, 2007-11 ,pp. : 279-286

Humana Press, Inc

Access to resources Recommend Favorite

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

By Shirota Hidekazu Klinman Dennis M

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 787-789

Future Medicine

Access to resources Recommend Favorite

Allergens and Asthma

By Platts-Mills Thomas A. E.

Allergy and Asthma Proceedings, Vol. 11, Iss. 6, 1990-11 ,pp. : 269-271

OceanSide Publications, Inc

Access to resources Recommend Favorite

Recombinant allergens for pollen immunotherapy

By Wallner Michael Pichler Ulrike Ferreira Fatima

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1323-1338

Future Medicine

Access to resources Recommend Favorite

Recombinant Allergens for Immunotherapy

By Chapman Martin D. Smith Alisa M. Vailes Lisa D. Pomés Anna

Allergy and Asthma Proceedings, Vol. 23, Iss. 1, 2002-01 ,pp. : 5-8

OceanSide Publications, Inc

Access to resources Recommend Favorite